[1]麦艳芬,钱怀萍,周瑞芳,等.性腺激素释放激素激动剂联合戊酸雌二醇对重度 子宫内膜异位症患者血清CA125、VEGF水平及 远期复发的影响[J].中国计划生育和妇产科,2017,(2):75-78.
　MAI Yan-fen,QIAN Huai-ping,ZHOU Rui-fang,et al.Effect of GnRHa combined with estradiol valerate on serum levels of CA125, VEGF and long-term recurrence in patients with severe endometriosis[J].Chinese Journal of Family Planning & Gynecotokology,2017,(2):75-78.
点击复制

性腺激素释放激素激动剂联合戊酸雌二醇对重度 子宫内膜异位症患者血清CA125、VEGF水平及 远期复发的影响
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年2期
页码:
75-78
栏目:
论著与临床
出版日期:
2017-02-25

文章信息/Info

Title:
Effect of GnRHa combined with estradiol valerate on serum levels of CA125, VEGF and long-term recurrence in patients with severe endometriosis
作者:
麦艳芬; 钱怀萍; 周瑞芳; 胡淑娟*; 霍泳贤
佛山市第五人民医院
Author(s):
MAI Yan-fen; QIAN Huai-ping; ZHOU Rui-fang; HU Shu-juan*; HUO Yong-xian
Department of Gynecology and Obstetrics, Foshan Fifth People 's Hospital， Foshan Guangdong 528211，P.R. China
关键词:
性腺激素释放激素激动剂; 戊酸雌二醇; 子宫内膜异位症; 反向添加疗法
Keywords:
gonadotropin releasing hormone agonist;  estradiol valerate;  endometriosis;  reverse adding therapy
分类号:
R 711.71
摘要:
目的探讨性腺激素释放激素激动剂(gonadotropin releasing hormone agonist,GnRHa)联合戊酸雌二醇反向添加疗法对重度子宫内膜异位症（endometriosis ,EMs）患者血清糖类抗原CA125、血管内皮生长因子（vascular endothelial growth factor ,VEGF）水平及远期复发的影响。方法将2013年5月至2014年5月在广东佛山市第五人民医院住院治疗的90例重症EMs患者进行保守腹腔镜手术治疗后按随机数字表法分为两组。对照组采用注射GnRHa治疗，研究组采用GnRHa联合戊酸雌二醇反向添加疗法治疗。对比两组疗效、抗原CA125及VEGF水平、不良反应、复发率发生情况。结果治疗后两组总有效率（9286 % vs 7857 %），差异无统计学意义（P>005）；两组治疗后CA125及VEGF水平较治疗前均显著降低，改善程度比较差异无统计学意义（P>005）；治疗后研究组不良反应如潮热出汗、失眠、关节痛、阴道干燥、性生活障碍、情绪异常的发生率显著低于对照组（P<005）。随访2年，两组复发率比较差异无统计学意义（P>005）。结论GnRHa能降低重度EMs保守腹腔镜术后患者CA125、VEGF水平，具有较高的疗效，但不良反应发生率高。GnRHa联合戊酸雌二醇反向添加疗法对疗效、复发率无影响，但能显著减少低雌激素水平带来的不良反应发生率，提高患者的生活质量。
Abstract:
ObjectiveTo investigate the effect of reverse add therapy with gonadotropin releasing hormone agonist (GnRHa) combined with estradiol valerate on serum levels of cancer embryo antigen CA125, vascular endothelial growth factor (VEGF) and recurrence of severe endometriosis (EMs) patients . Methods90 patients with severe EMs treated in Foshan Fifth People 's Hospital from May 2013 to May 2014 were randomly divided into two groups after conservative laparoscopic surgery. The control group was injected with GnRHa,and GnRHa combined with estradiol valerate was used in the research group. Compare the efficacy of the two groups, the levels of CA125 and VEGF, the incidence of adverse reaction and recurrence. ResultsTotal effective rate of the two groups was compared after treatment (9286% vs 7857%). There was no significant difference (P>005). After treatment, the levels of CA125 and VEGF in both groups were significantly lower than before treatment (P<005).But the difference between the two groups were not statistically significant (P>005). After treatment, incidence rate of side effects such as hectic fever and sweating, insomnia, joint pain, vaginal dryness, sexual life disorder and abnormal emotion in the research group were significantly lower than that of the control group.The difference was statistically significant (P<005). After two years of follow-up,recurrence rates of the two groups were compared and the difference was not statistically significant (P>005). ConclusionGnRHa can decrease the level of CA125 and VEGF in patients with severe EMs after conservative laparoscopic surgery with high curative effect, but the incidence of side effects is also high. GnRHa combined with estradiol valerate therapy has no significant effect on curative effect and relapse rate, but it can significantly reduce the incidence of side effects and improve the quality of life of patients with low estrogen levels.

参考文献/References:

［1］GARRY R. The effectiveness of laparoscopic excision of endometriosis［J］. Current Opinion in Obstetrics & Gynecology, 2004, 16(4): 299-303. ［2］陈灿，王冰．子宫内膜异位症诊断与治疗进展 ［J］．中华实用诊断与治疗杂志，2014，28（2）：114-115． ［3］谢幸，苟文丽．妇产科学［M］．第8版．北京：人民卫生出版社，2014：268-274． ［4］FENG Y J, SHEN J. Obstetrics and gynecology［M］. Beijing: people's medical publishing house, 2005: 57. ［5］仝佳丽，郎景和，冷金花，等．重度子宫内膜异位症腹腔镜术后联合GnRHa治疗效果及反加疗法的影响［J］．现代妇产科进展，2008，17（11）：839-842． ［6］张绍芬，龙琦琦，韩懿．难治性子宫内膜异位症的药物治疗 ［J］．中国实用妇科及产科杂志，2009，25（9）：665-668． ［7］周应芳．子宫内膜异位症的临床诊断和治疗 ［J］．中华妇产科杂志，2005，40 （1）：67-70． ［8］张小莎，黄作香，李萍．GnRHa联合反向添加戊酸雌二醇对重度子宫内膜异位症腹腔镜术后患者的疼痛感及远期复发率影响［J］．中国生化药物杂志，2016，36 （1）：134-136． ［9］Surrey E S, Hornstein M D. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up［J］. Obstetrics and Gynecology, 2002, 99 (5, 1): 709-719. ［10］董艳，周东霞．子宫内膜异位症患者治疗前后血清CA125,VEGF检测的临床意义［J］．放射免疫学杂志，2008，21（2）：127-129． ［11］甄小文，阙贵珍，冯满欢，等．GnRHa联合反加疗法治疗保守性手术后中重度子宫内膜异位症的临床分析 ［J］．中国现代医药杂志，2011，13 （4）：61-64． ［12］张庆霞，李喜英，张蕴霞，等．重度子宫内膜异位症术后使用GnRH-a与孕三烯酮的临床观察 ［J］．实用妇产科杂志，2015，31（2）：153-155．

相似文献/References:

[1]赵芳,秦翔娟,薛琦霞,等.戊酸雌二醇配伍米索前列醇在稽留流产中的应用价值[J].中国计划生育和妇产科,2014,(04):0.
　ZHAO Fang,QIN Xiang-juan,XUE Qi-xia,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[2]周萍,成燕,赵荣,等.戊酸雌二醇联合米索前列醇在绝经后妇女宫内节育器取出中的应用[J].中国计划生育和妇产科,2015,(01):0.
　ZHOU Ping,CHENG Yan,ZHAO Rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(2):0.

更新日期/Last Update: 2017-02-25